Biotinylated Human GUCY2C / Guanylyl cyclase C Protein, Fc,Avitag™
Proteins and Peptides
- 貨號 Cat. No.
- GUC-H82F8
- 規格 Size
- 200ug
- 品牌 Brand
- ACROBiosystems
- Species
- Human
- Conjugate
- Precision Avi
- Expression System
- HEK293
- Tag
- Avi Tag 、 Fc Tag
Description
Source :
Biotinylated Human GUCY2C, Fc,Avitag (GUC-H82F8) is expressed from human 293 cells (HEK293). It contains AA Ser 24 - Gln 430 (Accession # P25092-1).
Molecule : GUCY2C
Synonyms : GUCY2C,GUC2C,STAR,STA receptor,hSTAR,GC-C
Format : Powder
Category : MABSol® Biotin Labeled Proteins
Accession : NP_004954.2
Storage : -20℃
Shipping condition : Powder,RT
Molecular Weight : 74.1 kDa
Characteristics :
This protein carries a human IgG1 Fc tag at the C-terminus, followed by a Avi tag (Avitag™). The protein has a calculated MW of 74.1 kDa. The protein migrates as 90-110 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin Level : Less than 1.0 EU per μg by the LAL method.
Buffer : PBS, pH7.4
Description :
GUCY2C (Guanylyl Cyclase C), also known as heat-stable enterotoxin receptor, is a type I transmembrane protein of the guanylate cyclase (gc) family that signal by producing cGMP. Guanylate cyclase C (GUCY2C) and its hormones guanylin and uroguanylin have recently emerged as one paracrine axis defending intestinal mucosal integrity against mutational, chemical, and inflammatory injury. GUCY2C murine CAR-T cells recognized and killed human colorectal cancer cells endogenously expressing GUCY2C. Thus, we have identified a human GUCY2C-specific CAR-T cell therapy approach that may be developed for the treatment of GUCY2C-expressing metastatic colorectal cancer.
References :
(1) Magee MS, et al. Cancer Immunol Res. 2018. 6(5):509-516.
(2) Li P, et al. Cancer Res. 2017. 77(18):5095-5106.
(3) Arshad N, et al. J Biol Chem. 2013. 288(6):3907-17.

